Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongyang Huoxue Fang (通阳活血方颗粒) is a traditional Chinese medicine (TCM) formulation in granule form. It is designed to "invigorate yang" and "promote blood circulation," with the primary indications being ischemic cardiovascular and cerebrovascular diseases such as arteriosclerosis, cerebral thrombosis, and related conditions. The formula typically contains a combination of herbal ingredients known for their effects on promoting blood flow, resolving stasis, warming yang energy, and alleviating symptoms like limb weakness or paralysis due to poor circulation. Its mechanism of action is based on TCM principles—improving microcirculation, reducing blood viscosity, dispersing blood stasis—and may also involve anti-inflammatory effects and neuroprotection according to modern pharmacological studies[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tongyang huoxue fang.